Almost the same results were found in silymarin-treated rats (C) and SA 20 mg/kg treated rats (D) by the significant revitalization of hepatic cells and resistance of hepatic fibrosis in comparison to that of the TAA-treated positive control rats, as presented by moderate expression of α-SMA stain and lower mitotic index. The gene discussed is ACTA1; the disease is Hepatic fibrosis.